|
Market Closed -
Nasdaq
16:00:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 57.23 USD | +2.38% |
|
-5.76% | -13.80% |
| Market Cap | 8.08B 7.21B 6.68B 6.07B 11.39B 766B 11.58B 80.07B 31.48B 401B 30.33B 29.7B 1,281B | P/E 2026 * |
-15.9x | P/E 2027 * | -12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 7.25B 6.46B 5.99B 5.44B 10.22B 688B 10.38B 71.82B 28.24B 359B 27.21B 26.64B 1,149B | EV / Sales 2026 * |
15.6x | EV / Sales 2027 * | 22.5x |
| Free-Float |
94.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ARWR | Delayed | |
CBOE
| ARWR | Real-time | |
|
Xetra
| HDP1 | Delayed | |
|
Tradegate
| HDP1 | Real-time | |
|
Börse Stuttgart
| HDP1 | Delayed | |
|
Berne S.E.
| HDP1 | End-of-day quote | |
|
London S.E.
| 0HI3 | Delayed | |
|
Deutsche Boerse AG
| HDP1 | Delayed | |
|
Boerse Muenchen
| HDP1 | Real-time |
Last Transcript: Arrowhead Pharmaceuticals, Inc.
| 1 day | +2.38% | ||
| 1 week | -5.76% | ||
| Current month | -12.56% | ||
| 1 month | -13.91% | ||
| 3 months | -22.97% | ||
| 6 months | -17.67% | ||
| Current year | -13.80% |
| 1 week | 55.83 |  | 60.53 |
| 1 month | 55.83 | | 72.49 |
| Current year | 54.02 | | 95.49 |
| 1 year | 36.73 | | 95.49 |
| 3 years | 9.57 | | 95.49 |
| 5 years | 9.57 | | 95.49 |
| 10 years | 1.2 | | 95.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2007-11-30 | |
Daniel Apel
DFI | Director of Finance/CFO | - | 2025-05-12 |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | - | |
Mauro Ferrari
BRD | Director/Board Member | 66 | 2010-08-18 |
Michael Perry
BRD | Director/Board Member | 66 | 2011-12-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/18/26 | Sell | Director | -2,000 | 0.0014% | ||
| 8/18/26 | Sell | Director | -11,600 | 0.0082% | ||
| 6/15/26 | Free | Director | 11,882 | 0.0084% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.38% | -5.76% | +55.47% | +125.76% | 7.9B | |
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +1.52% | +6.83% | +10.77% | +79.30% | 51.2B | |
| +0.30% | -0.46% | +2.53% | +61.89% | 51.19B | |
| -0.38% | +1.40% | +29.98% | +42.37% | 43.93B | |
| +0.30% | +5.64% | +16.99% | +133.30% | 41.96B | |
| +2.35% | -6.08% | +236.69% | +528.10% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -8.45% | +37.09% | +4.90% | 25.2B | |
| +1.60% | +2.21% | +21.34% | +28.00% | 22.5B | |
| Average | +1.08% | -1.09% | +48.14% | +113.07% | 38.03B | |
| Weighted average by Cap. | +1.00% | -0.34% | +46.23% | +112.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 464M 414M 383M 348M 654M 44B 665M 4.6B 1.81B 23B 1.74B 1.7B 73.52B | 328M 293M 271M 246M 462M 31.12B 470M 3.25B 1.28B 16.26B 1.23B 1.21B 51.99B |
| Net income | -513M -457M -423M -385M -722M -48.6B -734M -5.08B -2B -25.4B -1.92B -1.88B -81.2B | -663M -591M -548M -498M -934M -62.88B -950M -6.57B -2.58B -32.86B -2.49B -2.44B -105B |
| Net Debt | -832M -742M -687M -625M -1.17B -78.92B -1.19B -8.24B -3.24B -41.25B -3.12B -3.06B -132B | -683M -609M -564M -513M -962M -64.73B -978M -6.76B -2.66B -33.83B -2.56B -2.51B -108B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | US$57.23 | +2.38% | 1,646,983 |
| 26-10-16 | US$55.90 | -4.44% | 1,773,598 |
| 26-10-15 | US$58.50 | +0.22% | 2,009,593 |
| 26-10-14 | US$58.37 | +0.41% | 4,160,277 |
| 26-10-13 | US$58.13 | -4.28% | 2,260,925 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARWR Stock
Select your edition
All financial news and data tailored to specific country editions
